Site Map

• RITUXAN^® (Rituximab) Home
• About Non-Hodgkin's Lymphoma
  • NHL Defined
  • Signs, Symptoms & Diagnosis
  • Staging & Grading
  • Treatment Options
• About RITUXAN
• RITUXAN for Indolent (Low-Grade) NHL
  • Initial Treatment
  • Ongoing Therapy
  • Treatment Upon Relapse
  • Indolent NHL: Before & After Therapy
  • Safety Information
• RITUXAN for Aggressive NHL
  • Initial Treatment
  • Aggressive NHL: Before & After Therapy
  • Safety Information
• Tools & Resources
  • Patient Resources & Materials
  • Caregiver Resources & Materials
  • Questions & Answers
    • Questions to Ask Your Doctor
    • Glossary of Terms
  • Living With Lymphoma
  • Reimbursement
  • Links
• Important Safety Information
• Privacy Policy
• Terms & Conditions
• Copyright

INDICATIONS

RITUXAN^® (rituximab) is indicated for the treatment of patients with:

• Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent
• Previously untreated follicular, CD20-positive, B-cell NHL in combination with CVP chemotherapy
• Non-progressing (including stable disease), low-grade, CD20-positive B-cell NHL, as a single agent, after first-line CVP chemotherapy
• Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens

IMPORTANT SAFETY INFORMATION

RITUXAN can cause serious side effects, some of which can be life-threatening, including: Progressive Multifocal Leukoencephalopathy (PML), infusion reactions, Tumor Lysis Syndrome (TLS), and severe skin reactions. Other serious and life-threatening side effects with RITUXAN include: hepatitis B virus reactivation, heart problems, infections, and stomach and bowel problems. Common side effects during RITUXAN infusions include: fever, headache, chills and shakes, nausea, itching, hives, cough, sneezing, and throat irritation or tightness.

Tell your doctor about any side effects that bother you or that do not go away. These are not all of the possible side effects with RITUXAN. Ask your doctor for more information.

Please read the Medication Guide in HTML or PDF versions for more information.